China has Biological WEAPONS with the Ability to KILL based on RACE

China has Biological WEAPONS with the Ability to KILL based on RACE

China has Biological WEAPONS with the Ability to KILL based on RACE.

Are race targeting biological weapons possible? Yes very possible and very real. Read on to find out more.

Bioweapon logo. China has Biological WEAPONS with the Ability to KILL based on RACE.

Believe me, I know most of the following sounds like futuristic science fiction that you don’t need to think about, but it’s not. The future is here and although I hope you don’t actively worry about it, it’s something worth knowing. I came across an article discussing China creating Bioweapons to target people by race and started digging a little deeper. Here, I’ll share what I found. The sources I noted from are at the bottom of the page.

The Warning

Scientists warn that humans should be worried about being wiped out by a killer pathogen that is specifically designed to kill people of only a particular race, based on their genetic material/ Deoxy ribonucleic Acid (DNA).

A new report from Cambridge University’s Centre for the Study of Existential Risk says that world governments have failed when it comes to preparing against threats like futuristic bioweapons powered by Artificial Intelligence (AI) and genetic manipulation. Such weapons would have to power to target specific DNA, and kill certain races of people leaving other swaths of the population unharmed.

Imagine it being sprayed in the form of the tinfoil hat conspiracy of chemtrails, and wiping out certain portions of the population. The authors warn: “The technology is becoming increasingly sophisticated at ever cheaper prices, democratising the ability to harm more quickly and lethally. In a particularly bad case, a bio-weapon could be built to target a specific ethnic group based on its genomic profile”.

Scientist in a lab. China has Biological WEAPONS with the Ability to KILL based on RACE.

A biological weapon is any infectious agent, such as bacteria, virus or toxin, which is used intentionally to inflict bodily harm to people, animals or nature. They can be used to cause massive casualties, social disruption, economic losses, and environmental problems as a means of warfare or terrorism. Biological weapons are difficult to handle after release because they are infectious agents that spread uncontrollably beyond the target area.

Rapid scientific developments and the possible misuses of scientific achievements to create biological weapons make this an area of growing concern for the disarmament community.

The number of states with the capacity to make biological weapons is over 100. Due to the secrecy with which such programmes are conducted and the fact that facilities for producing biological weapons are easier to hide than the ones for nuclear and chemical weapons, it is hard to know exactly how many states possess biological weapons or to detect bio-weapons programmes. A further problem is the dual-use nature of many installations; it is difficult to distinguish defensive from offensive uses.

The technology is becoming increasingly sophisticated at ever-cheaper prices, democratizing the ability to harm more quickly and lethally. In a particularly bad case, a bio-weapon could be built to target a specific ethnic group based on its genomic profile,” wrote the authors of the study report.

“I believe that China is a threat to the United States and to the international community. I also believe it’s more than just a competitor, as president Biden has said, and it’s more than just an adversary. It is actually our enemy. We don’t need to speculate about that because in May 2019, People’s Daily, the most authoritative publication in China, declared a “people’s war” on the United States. That’s more than just rhetoric,” 

Gordon G. Chang 
Big pregnancy test. China has Biological WEAPONS with the Ability to KILL based on RACE.

China’s Secret DNA Sampling Scheme

A chinese gene company selling prenatal tests around the world developed them in collaboration with the country’s military and is using them to collect genetic data from millions of women for sweeping research on the traits of populations, a Reuters review of scientific papers and company statements found.

U.S. government advisors warned in March that a vast bank of genomic data that the company, BGI Group, is amassing and analyzing with artificial intelligence could give China a path to economic and military advantage. As science pinpoints new links between genes and human traits, access to the biggest, most diverse set of human genomes is a strategic edge. The technology could propel China to dominate global pharmaceuticals, and also potentially lead to genetically enhanced soldiers, or engineered pathogens to target the U.S. population or food supply, the advisors said.

Reuters has found that BGI’s prenatal test, one of the most popular in the world, is a source of genetic data for the company, which has worked with the Chinese military to improve “population quality” and on genetic research to combat hearing loss and altitude sickness in soldiers.

BGI says it stores and re-analyzes left-over blood samples and genetic data from the prenatal tests, sold in at least 52 countries to detect abnormalities such as Down syndrome in the fetus. The tests – branded NIFTY for “Non-Invasive Fetal TrisomY” – also capture genetic information about the mother, as well as personal details such as her country, height and weight, but not her name, BGI computer code viewed by Reuters shows.

So far, more than 8 million women have taken BGI’s prenatal tests globally. BGI has not said how many of the women took the test abroad, and said it only stores location data on women in mainland China.

“A prenatal blood test NIFTY taken by more than 8 million pregnant women globally in at least 52 countries was developed by a Chinese gene company BGI Group in collaboration with the Chinese military and is being used by the firm to collect and analyse genetic data. It sends leftover blood samples to Hong Kong”.The test’s privacy policy says data collected can be shared in China when it is “directly relevant to national security or national defence security”. 


The tests are a private procedure for the women who take them, a component in their routine prenatal care. But the studies show that they yield increasingly potent information for research.

One BGI study, for instance, used a military supercomputer to re-analyze NIFTY data and map the prevalence of viruses in Chinese women, look for indicators of mental illness in them, and single out Tibetan and Uyghur minorities to find links between their genes and their characteristics.

The scale of BGI’s accumulation of prenatal data, and its collaboration with the military in prenatal and neonatal research, have not been previously reported. The company has published at least a dozen joint studies on the tests with the People’s Liberation Army (PLA) since 2010, trialling and improving the tests or analyzing the data they provided, the Reuters review found.

DNA data collected from prenatal tests on women outside China has also been stored in China’s government-funded gene database, one of the world’s largest, the company confirmed. BGI, in which the Shenzhen city government and Beijing’s largest state investment vehicle took stakes in 2014, runs that gene bank.

Reuters found no evidence BGI violated patient privacy agreements or regulations. However, the privacy policy on the NIFTY test’s website says data collected can be shared when it is “directly relevant to national security or national defense security” in China.

Beijing made clear in a 2019 regulation that genetic data can be a national security matter, and since 2015 it has restricted foreign researchers from accessing gene data on Chinese people. In contrast, the United States and Britain give foreign researchers access to genetic data, as part of open science policies.

BGI said in a statement it “has never been asked to provide – nor provided – data from its NIFTY tests to Chinese authorities for national security or national defense security purposes.”

Other companies selling such prenatal tests also re-use data for research. But none operate on the scale of BGI, scientists and ethicists say, or have BGI’s links to a government or its track record with a national military.

News BGI developed the prenatal tests with the PLA comes as international scrutiny is increasing over China’s use of civilian technology for military modernization. NATO has warned China’s assertive behavior is a systemic challenge, and Beijing has drawn sanctions for alleged human rights violations in Xinjiang and stepped up a national security crackdown in Hong Kong.

The findings offer new insight into how BGI is using vast computing power to unlock genomic secrets. Previously, Reuters revealed how the company rapidly expanded its gene-sequencing labs globally and gained a role in other nations’ health systems, and how it worked with China’s military on research ranging from mass testing for respiratory pathogens to brain science.

China has Biological WEAPONS with the Ability to KILL based on RACE.

The Reuters examination also sheds new light on concerns expressed by a U.S. expert panel, the U.S. National Security Commission on Artificial Intelligence (NSCAI), led by former Google chief executive Eric Schmidt. The panel said in March that the United States should recognize China’s strides towards global leadership in biotechnology and AI as a new kind of national security threat, and boost funding for its own research to counter China’s state-driven effort.

China’s Ministry of Foreign Affairs said the reporting in this article reflected “groundless accusations and smears” of U.S. agencies. The PLA did not respond. China has released new privacy and data security laws that offer greater protection of personal data, but also allow Chinese national security authori

When you can combine large amounts of genomic data – including mothers and their unborn children – with their medical data and history, it is really powerful.”

Anna Puglisi, former U.S. counterintelligence officer

The data offer insight into foreign populations as well as China’s own. Computer instructions that BGI uses to process the NIFTY data show it collects a wide range of information about customers besides their genetic code. This includes the women’s country, medical history and the sex of the fetus, according to the instructions, reviewed by Reuters on a programmers’ forum online.

Reuters reviewed more than 100 documents, from research papers to marketing materials, to determine the scope of data being captured by BGI through its prenatal tests, how it is using this in its research and its military collaboration. Reuters also interviewed more than two dozen scientists and experts in genetic law, including researchers who worked with the company, as well as four women, in Poland, Spain and Thailand, who took the tests.

The women, who signed consent forms stating that their genetic data would be stored and used for research, said they did not realize their genetic information could end up in China. For example, one of them, a 32-year-old office administrator in Poland, signed a BGI form agreeing to have her sample sent to Hong Kong and her genetic data retained, but the form did not say where it would be held, or make clear that BGI’s headquarters and research base are in Shenzhen.

The woman, Emilia, spoke on the condition that only her first name be used. She said that if she had known that, and understood the extent of BGI’s secondary research, she would have chosen a different test.

“I want to know what is happening with such sensitive data about me, such as my genome and that of my child,” she said. “This could be a very important matter when choosing a test. For me it would be.”

It was also unclear to the other women where their data was stored.

The Gene Bank website acknowledges the “NIFTY database” as among its “rich sources of biological data.”

BGI patented its tests in 2011 and began marketing them abroad in 2013. Within three years, more than 2,000 healthcare providers globally were selling them, according to BGI marketing materials. In 2019, the last full year before the COVID-19 pandemic, BGI reported that 42% of its sales of 2.8 billion yuan ($433 million) came from its reproductive health division. Prenatal tests are the major contributor.

As gene sequencing technology has expanded worldwide, so has the scope of NIPT tests on offer. BGI’s now reveal 84 genetic conditions that affect the pregnancy of women under 40, and sex chromosome disorders that can cause learning delays.

The tests sequence about a tenth of the mother’s genome, said Dennis Lo, the Hong Kong scientist who pioneered the technique independently in 1997.

“And so you can imagine if you got a tenth of the genome sequence and you pull it from millions of people – let’s say 10 million every year – I think that would be quite powerful.”

Military Medicine

The hospital is at the forefront of Chinese genetic research on deafness, and its head of obstetrics, Lu Yanping, was developing a prenatal test for deafness and Down syndrome. In April 2011, Lu began a clinical trial of NIFTY with BGI on 3,000 women in the hospital clinic, a published study shows. Neither Lu nor the hospital responded to requests for comment.

In August 2010 BGI start

ed work with another military institution, the Third Military Medical University in Chongqing. Liang Zhiqing, vice chairman of the PLA’s Institute of Obstetrics and Gynecology, and BGI researchers have published at least five joint studies based on data from women who took the test at the university’s prenatal clinic.

Liang’s work was funded by the Chinese government as a “Military Medicine Innovation Project,” and the samples were sequenced in a BGI “joint laboratory” at the university, according to a paper in the European Journal of Medical Genetics. Liang did not respond to a request for comment.

The university and BGI ran conferences on preventing birth defects and “improving population quality,” conference promotion shows. The PLA was closely involved in a foundation to prevent birth defects, led by a key figure in the implementation of China’s One Child Policy, from 2011.

A BGI executive was among the experts at its first meeting, which heard that “birth defects not only affect the health and quality of life of children, but also the quality of the country’s population and manpower.” A plan to promote screening for 48 genetic and metabolic diseases was approved.

For more than a decade, scientists worldwide have searched for a cost-effective way to study the genetic profiles of a whole population of people. A handful of efforts reached tens of thousands of participants, but anything larger stalled on cost and logistics, BGI researchers wrote in a 2018 scientific paper published in Cell.

Left-over samples and test data from prenatal tests meant BGI could run studies on an unprecedented scale.

In the Cell paper, BGI researchers said they had performed the largest study of Chinese population genetics ever – which they undertook with 141,000 re-used prenatal tests. The tests, they said, “provide an untapped resource” to understand how people’s genes relate to their characteristics, and to their susceptibility to viruses.

This, they said, could offer “considerable mapping power.”

The researchers were able to see genes associated with bipolar disease, schizophrenia, immune response and resistance to malaria. They were able to link genes to height and percentage of body fat as well as to a diet high in animal fat.

And they were able to track viruses including hepatitis B – which they found to be relatively common among the Chinese population – and two types of herpes virus, which they said were more prevalent among Europeans. “We … reveal a different viral sequencing distribution spectrum compared to Europeans,” the researchers wrote.

A biology professor at the University of California, Berkeley, Rasmus Nielsen, advised BGI researchers on how to extract information from the prenatal test data for the study.

“It’s amazing that this is even possible,” he told a Berkeley newsletter in 2018. “You can take these massive samples and do association-mapping to see what the genetic variants are that explain human traits.”

The researchers were also able to trace genetic distinctions between the country’s dominant Han Chinese ethnic group and minorities including Uyghurs and Tibetans, and look at population movements and intermarriage caused by Chinese government policy since 1949. This data was later released to other Chinese researchers studying how “significantly different” genetic variations in Uyghurs affected their response to drugs, a 2019 scientific paper shows.

China’s collection and analysis of the DNA of its Uyghur Muslim population – including systematic collections of samples from residents in Xinjiang – has drawn sharp criticism. The United States sanctioned two BGI subsidiaries last year for what it called China’s “abusive DNA collection and analysis schemes to repress its citizens.” BGI denied it was involved in any human rights abuses in Xinjiang. China’s foreign ministry said health check-ups of Uyghurs there did not collect biological information such as DNA.

UC Berkeley’s Nielsen told Reuters he no longer worked with BGI. He chose to end a decade-long collaboration soon after the 2018 study was published in Cell, because changes to Chinese law restricted foreign researchers working with Chinese genomic data, he said.

This information should terrify anyone who isn’t Chinese. While I’m absolutely certain the United States Military is studying similar weapons programs through their black projects the fact that China has declared a capability with intent to release a bio weapon targeted to specific races and other genetic traits is scary to say the least.

Source #1

Source #2

Source #3

China has Biological WEAPONS with the Ability to KILL based on RACE.